Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.
暂无分享，去创建一个
P. Fayers | D. Girling | R. Stephens | N. Bleehen | Mr P.M. Fayers Dr D.J. Girling and Mr R.J. Stephens . Prepared on behalf of the participating member
[1] R. Livingston. Current chemotherapy of small cell lung cancer. , 1986, Chest.
[2] J. Herman,et al. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] P M Fayers,et al. Measuring and analysing quality of life in cancer clinical trials: a review. , 1983, Statistics in medicine.
[4] R. Simon,et al. Patient subsets and variation in therapeutic efficacy. , 1982, British journal of clinical pharmacology.
[5] G. Deboer,et al. Combined modality treatment of small cell carcinoma of the lung. , 1981, Archives of internal medicine.
[6] H. Earl,et al. Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancer. , 1988, Antibiotics and chemotherapy.
[7] H. Hansen,et al. Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. , 1983, Cancer treatment reports.
[8] T. Pajak,et al. A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy‐radiation therapy versus cyclophosphamide‐radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation , 1980, Cancer.
[9] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .